About Martin Heidecker
Form D filings for Venatorx Pharmaceuticals from 2022 to 2023 list Martin Heidecker as director.
Martin Heidecker first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Heidecker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Heidecker works with at each company, as listed on that company's latest Form D.
Venatorx Pharmaceuticals, Inc. · Form D/A, Jul 13, 2023
TH
Timothy Haines
Director
TH
Tomas Heyman
Director
CB
Christopher Burns
President and director
DP
Daniel Pevear
Executive officer
AM
Anthony Meehan
Executive officer
SP
Sergei Petukhov
Director